文献速递乳房整形与再造显微修复重建

自体乳房再造住院时长关键分析:NSQIP数据库研究

A Critical Examination of Length of Stay in Autologous Breast Reconstruction: A National Surgical Quality Improvement Program Analysis.
PubMed 文献 · Plast Reconstr Surg · 2021-01-01

回归分析显示体重指数、糖尿病、恶性肿瘤史、手术时间超过500分钟及乳房切除后即刻再造是延长住院的独立危险因素,2017年手术风险较低。

要点

  • 34%的游离组织移植乳房再造患者术后住院超过5天。
  • 手术时间超过500分钟、即刻再造、糖尿病、恶性肿瘤史及BMI升高增加延长住院风险。
  • 2017年手术较早期年份延长住院风险更低(OR 0.2)。

核心结论

  • 游离组织移植乳房再造术后延长住院与患者因素及手术因素独立相关,可用于术前风险分层。

主要发现

  • 延长住院(>5天)发生率为34%。
  • 体重指数(OR 1.5,95%CI 1.2-1.9,p<0.001)、糖尿病(OR 1.3,95%CI 1.1-1.6,p=0.003)、恶性肿瘤史(OR 1.9,95%CI 1.22-3.02,p=0.005)与延长住院独立相关。
  • 手术时间>500分钟(OR 3,95%CI 2.73-3.28,p<0.001)和乳房切除后即刻再造(OR 1.7,95%CI 1.16-2.48,p<0.001)增加延长住院风险。
  • 双侧游离组织移植无统计学意义;2017年手术延长住院风险较低(OR 0.2,95%CI 0.06-0.81,p=0.02)。
  • 再手术在术中输血和双侧游离组织移植后更常见,同期异体组织移植后更少见。

关键数值与推荐

  • 延长住院定义为术后住院时间大于5天。
  • 术后住院天数(天)可通过公式计算:住院时长=2.559+0.003×手术时间(分钟)。

临床怎么用

  • 术前可依据BMI、糖尿病、恶性肿瘤史、预计手术时间及再造时机对患者进行延长住院风险分层,优化围手术期决策。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aims to use the National Surgical Quality Improvement Program database to identify factors associated with extended postoperative length of stay after breast reconstruction with free tissue transfer. METHODS: Consecutive cases of breast reconstruction with free tissue transfer were retrieved from the National Surgical Quality Improvement Program (2005 to 2017) database using CPT code 19364. Extended length of stay (dependent variable) was defined as greater than 5 days. RESULTS: Nine thousand six hundred eighty-six cases were analyzed; extended length of stay was noted in 34 percent. On regression, patient factors independently associated with extended length of stay were body mass index (OR, 1.5; 95 percent CI, 1.2 to 1.9; p < 0.001), diabetes (OR, 1.3; 95 percent CI, 1.1 to 1.6; p = 0.003), and malignancy history (OR, 1.9; 95 percent CI, 1.22 to 3.02; p = 0.005). Operation time greater than 500 minutes (OR, 3; 95 percent CI, 2.73 to 3.28; p < 0.001) and immediate postmastectomy reconstruction (OR, 1.7; 95 percent CI, 1.16 to 2.48; p < 0.001) conferred risk for extended length of stay. Bilateral free tissue transfer was not significant. Operations performed in 2017 were at lower risk (OR, 0.2; 95 percent CI, 0.06 to 0.81; p = 0.02) for extended length of stay. Reoperation is more likely following operative transfusion and bilateral free tissue transfers, but less likely following concurrent alloplasty. Given a known operation time (minutes), postoperative length of stay (days) can be calculated using the following equation: length of stay = 2.559 + 0.003 × operation time. CONCLUSIONS: This study characterizes the risks for extended length of stay after free tissue transfer breast reconstruction using a prospective multicenter national database. The result of this study can be used to risk-stratify patients during surgical planning to optimize perioperative decision-making. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Kotha VS, Abadeer AI, Amdur RL, et al. A Critical Examination of Length of Stay in Autologous Breast Reconstruction: A National Surgical Quality Improvement Program Analysis. Plast Reconstr Surg. 2021. PMID: 33002979. doi:10.1097/PRS.0000000000007420

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。